LillyDirect vs NovoCare vs Telehealth: 2026 Channel Comparison

Introduction

The cheapest way to get a brand GLP-1 without insurance in 2026 is usually direct from the manufacturer, but the cheapest way to get a GLP-1 at all is usually a compounded telehealth program. Those are two different products at two different price points, and the channel you pick shapes your monthly cost, your clinical support, and how likely you are to still be on therapy a year from now.

LillyDirect and NovoCare Pharmacy exist because roughly half of commercially insured Americans still had no weight loss drug coverage heading into 2026. The manufacturers built cash channels to capture those patients. Telehealth programs answer the same problem from the other direction, with lower-cost compounded options and a service layer the manufacturers don’t provide.

At TrimRx, we believe you should see every channel’s real numbers before committing to any of them. If you want to know what a personalized program would cost you specifically, the free assessment quiz is the fastest way to find out.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

What Is LillyDirect and What Does It Cost?

LillyDirect is Eli Lilly’s direct-to-patient platform. It connects you with independent telehealth prescribers and fills Zepbound® prescriptions through its self-pay pharmacy channel. Zepbound single-dose vials launched at $349 a month for the 2.5 mg starting dose and $499 a month for higher strengths, with discounted pricing for on-time refills.

Quick Answer: LillyDirect sells Zepbound® vials self-pay, launched at $349 a month for the starting dose and $499 for higher doses, with refill discounts.

You’re buying the FDA-approved brand product, shipped to your door, without insurance involvement. That’s the pitch, and for brand loyalists it’s a clean one.

What you’re not buying is much of a clinical program. LillyDirect connects you to third-party prescribers, but ongoing coaching, dose strategy, and side effect management are largely on you and whatever provider relationship you build. Lilly is a drug company, not a care company, and the experience reflects that.

What Is NovoCare Pharmacy and What Does It Cost?

NovoCare Pharmacy is Novo Nordisk’s answer, launched in March 2025 with Wegovy® at $499 a month cash for all dose strengths, shipped direct. Since launch, Novo has run promotional starting-dose pricing at points, and oral Wegovy joined the lineup after its 2026 approval, giving needle-averse patients a brand pill option in the same channel.

The flat all-doses price matters. Some channels charge more as you titrate up; NovoCare’s model means your month 6 price matches your month 1 price.

Like LillyDirect, NovoCare is a fulfillment channel more than a care program. You still need a prescriber, and the support layer is thin. It’s a strong option if you’ve already got a physician managing your treatment and you just need the medication at a workable cash price.

How Does TrumpRx Fit Into the Direct-pricing Picture?

TrumpRx, live in 2026 following the pricing agreements both manufacturers signed in late 2025, lists brand GLP-1s at federally negotiated cash prices, generally in the few-hundred-dollars-a-month range with lower launch pricing on starting doses. For some doses it undercuts the manufacturers’ own direct channels.

Treat it as a third storefront for the same brand products. The drug is identical; the checkout differs. Prices across TrumpRx, LillyDirect, and NovoCare have all moved since launch, so the winner changes by drug, dose, and month.

The same caveat applies: TrumpRx sells medication, not care. You bring your own prescription and your own plan for titration, side effects, and plateaus.

What Do Telehealth GLP-1 Programs Actually Include?

A telehealth program bundles the prescription, the medication, and ongoing clinical management into one monthly price. That typically means an intake evaluation, a licensed prescriber, dose adjustments as you titrate, side effect support between visits, and refill logistics handled for you.

Programs like TrimRx, FormBlends, and HealthRX.com work with 503A compounding pharmacies, which prepare medication for a specific patient under a personalized prescription. Compounded semaglutide programs commonly run $199 to $399 a month in 2026, and compounded tirzepatide programs roughly $329 to $499.

The clinical layer is the real difference. GLP-1 dosing is not set-and-forget. Nausea management, titration pace, and plateau strategy all benefit from a prescriber who answers messages, and that’s the part manufacturer channels don’t sell.

Brand vs Compounded: What’s the Honest Difference?

Brand Zepbound and Wegovy are FDA-approved products with the full trial record behind them: 14.9% average weight loss for semaglutide 2.4 mg in STEP 1 (Wilding 2021, NEJM) and 20.9% for tirzepatide 15 mg in SURMOUNT-1 (Jastreboff 2022, NEJM). Compounded versions contain the same active ingredient class but are not FDA-approved and haven’t run their own trials.

That’s the trade. Compounded programs are legal through state-licensed 503A pharmacies when prescribed for an individual patient, and in 2026 they’re often $100 to $300 a month cheaper than brand direct pricing. But nobody should claim equivalence, and we don’t.

If budget is no object, brand is the conservative choice. If a $200 difference decides whether you stay on therapy past month 4, that math matters clinically too, because stopping early usually means regaining the weight.

Which Channel Is Cheapest in 2026?

For most cash-pay patients, compounded telehealth programs are cheapest, typically $199 to $499 all-in monthly. Brand direct channels (LillyDirect, NovoCare, TrumpRx) cluster from roughly $349 to $499 depending on drug and dose. Brand through insurance with a copay card beats everything at $25 a fill, but only if your plan covers the drug.

Hidden costs shift the ranking. Manufacturer channels may leave you paying separately for the prescriber visit. Telehealth bundles usually include it. And a channel that saves $50 a month but offers no support is expensive if poor side effect management knocks you off therapy.

Run the full-year number, not the first-month number, including visits and any titration price steps.

Key Takeaway: Manufacturer channels sell you the drug. Telehealth programs sell you the drug plus a clinical relationship, dose adjustments, and ongoing support.

Which Channel Offers the Best Ongoing Care?

Telehealth programs win this category, and it isn’t close. Manufacturer channels are pharmacies with a referral layer. A dedicated program assigns you a provider who tracks your dosing history, adjusts when nausea hits, and has a plan when the scale stalls at month 5.

That support shows up in adherence. Real-world analyses have repeatedly found that a large share of GLP-1 patients discontinue within a year, with pharmacy claims studies putting one-year discontinuation above 50% in some cash-pay populations. Cost and unmanaged side effects are the two leading reasons. A channel that addresses both is doing more than shipping vials.

If you already have an engaged physician managing your weight care, the manufacturer channels work fine. Most cash-pay patients don’t.

When Does Each Channel Make the Most Sense?

Pick LillyDirect if you specifically want brand tirzepatide, you’re comfortable self-managing, and the vial pricing fits your budget. Pick NovoCare if you want brand semaglutide, especially oral Wegovy, with flat pricing across doses. Pick TrumpRx if it lists your drug and dose below the manufacturer’s own channel that month.

Pick a telehealth program if you want the lower compounded price point, you value built-in clinical support, or you’ve tried medication before and quit because nobody helped you through the rough weeks.

There’s no loyalty prize. Plenty of patients start compounded, lose 30 pounds, then move to brand maintenance when coverage opens up. Channels are tools.

What About Insurance, HSAs, and the Paperwork Side?

Direct channels are cash channels, but cash doesn’t mean tax-disadvantaged. Prescribed GLP-1 therapy for a diagnosed condition is generally HSA and FSA eligible, which effectively discounts every channel in this comparison by your marginal tax rate. A $499 NovoCare fill paid with pre-tax dollars costs a 24%-bracket household closer to $380 in real terms, and the same logic applies to telehealth program fees with a prescription behind them.

Keep invoices regardless of channel. Manufacturer pharmacies issue standard receipts; telehealth programs issue monthly invoices that document the prescriber relationship. Both support HSA claims and, in high-spend years, the itemized medical deduction above 7.5% of adjusted gross income.

One more administrative note: if your insurance status changes mid-year, every channel lets you leave without penalty. None of the major direct or telehealth options lock you into annual contracts, so a new job with real GLP-1 coverage should trigger an immediate re-shop. The $25 copay tier beats everything in this article.

How Will the 2026 Pipeline Change This Comparison?

The channel war is about to get more crowded, which favors patients. Oral Wegovy is approved and flowing through NovoCare, giving the needle-averse a brand pill at direct pricing. Behind it, CagriSema posted 22.7% average weight loss in the REDEFINE 1 trial, and oral candidates like VK2735 continue through development. That’s trial data so far, not pharmacy shelves, but every approval adds a price competitor.

Expect manufacturers to keep adjusting direct prices downward as competition stacks, and expect telehealth programs to keep pricing below whatever brand floor exists. The structure of the decision (medication-only channels versus bundled care channels) should stay stable even as the numbers move.

Practical takeaway: lock in the best current channel, but re-shop every six months. This market rewards patients who treat pricing as a moving target.

Path Forward

Write down three numbers before you choose: your monthly price at month 1, your monthly price at full titration, and your total year-one cost including visits. Compare those across one manufacturer channel and one telehealth program, then pick the one you can sustain for 12 months, because sustained is the only version that works.

If you want the telehealth side of that comparison filled in with real numbers for your situation, TrimRx’s free assessment quiz takes a few minutes and tells you whether a personalized compounded program is a fit, with transparent monthly pricing before you commit to anything.

Bottom line: The right channel depends on whether you want brand medication, how much support you need, and what you can pay monthly without quitting.

FAQ

Is LillyDirect Cheaper Than NovoCare?

They sell different drugs, so it’s not a direct swap. LillyDirect’s Zepbound vials launched at $349 to $499 a month by dose; NovoCare’s Wegovy runs $499 flat across doses, with promotional starting-dose pricing at times. Compare at your actual dose, and check TrumpRx for both, since its negotiated prices sometimes undercut either.

Do I Need a Prescription for LillyDirect or NovoCare?

Yes. Both are pharmacy channels, not prescribers. LillyDirect connects you to independent telehealth providers; NovoCare fills prescriptions from your existing clinician or a partner service. A telehealth program bundles the prescribing step into the same monthly price instead.

Are Compounded GLP-1s Legal in 2026?

Yes, through state-licensed 503A compounding pharmacies when prescribed for an individual patient with personalization. Compounded medications are not FDA-approved and aren’t claimed to be equivalent to brand products. Reputable programs are upfront about that distinction.

Why Would Anyone Pay More for a Telehealth Program Than a Manufacturer Channel?

Usually they don’t pay more; compounded programs typically cost less. When prices are close, the telehealth premium buys ongoing clinical management: titration adjustments, side effect help, and someone accountable when progress stalls. Manufacturer channels ship medication and little else.

Can I Switch Channels Mid-treatment?

Yes, and people do it often. Moving between brand channels is just a pharmacy change. Moving between brand and compounded requires your prescriber to write a new prescription and map your current dose. A good program handles that transition for you rather than making you start over.

Is Oral Wegovy Available Through These Channels?

Yes. Following its 2026 approval, oral Wegovy ships through NovoCare’s direct channel at cash pricing, giving needle-averse patients a brand pill option without insurance. Telehealth programs continue to center on injectable compounded semaglutide and tirzepatide, so the pill specifically points you toward Novo’s channel for now.

Does Insurance Work with LillyDirect or NovoCare?

These channels are built for self-pay. If you have commercial insurance that covers your GLP-1, you’ll almost always do better at a regular pharmacy with the manufacturer copay card, which can bring fills down to around $25. The direct channels exist for everyone insurance leaves out.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.